Cabozantinib significantly improved progression free survival in patients with pNET and epNET compared with placebo.

T1 Tumor limited to the pancreas and size <2 cm T2 Tumor limited ... M: Metastasis; N: Node; T: Tumor. Data from [21]. Neuroendocrine tumors have demonstrated an increase in incidence and ...

Pancreatic tumors are either exocrine or neuroendocrine (endocrine) tumors. Knowing the type of tumor is important because each type behaves differently and responds to different treatments.

The FDA has approved Cabometyx for some patients 12 years old and older with previously treated neuroendocrine tumors.

Germline and Somatic Testing Guidelines and Challenges Guidelines now recommend germline panel testing for all patients diagnosed with pancreatic cancer (excluding neuroendocrine tumors), regardless ...

Cabometyx is approved for treating well-differentiated pancreatic and extra-pancreatic neuroendocrine tumors in patients 12 years and older. The phase 3 CABINET trial showed improved progression-free ...

T1 Tumor limited to the pancreas and size <2 cm T2 Tumor limited ... M: Metastasis; N: Node; T: Tumor. Data from [21]. Neuroendocrine tumors have demonstrated an increase in incidence and ...